Vitreous form of known bradykinin antagonist
    1.
    发明授权
    Vitreous form of known bradykinin antagonist 失效
    已知缓激肽拮抗剂的玻璃体形式

    公开(公告)号:US07094899B2

    公开(公告)日:2006-08-22

    申请号:US10301614

    申请日:2002-11-22

    IPC分类号: C07D215/38 A61K31/47

    CPC分类号: C07D401/12

    摘要: This invention relates to a vitreous form of 8-[3-[N-[(E)-3-(6-acetamidopyridin-3-yl)acryloylglycyl]-N-methylamino]-2,6-dichlorobenzyloxy]-2-methylquinoline (FR173657). This vitreous form has good solid stability and, therefor, is useful for producing and supplying FR173657 products whose quality is stable enough to be suitable for medicines.

    摘要翻译: 本发明涉及玻璃体形式的8- [3- [N - [(E)-3-(6-乙酰氨基吡啶-3-基)丙烯酰基甘氨酰] -N-甲基氨基] -2,6-二氯苄氧基] -2-甲基喹啉 (FR173657)。 这种玻璃体形式具有良好的固体稳定性,因此可用于生产和供应质量稳定至适合药物的FR173657产品。